Elevated levels of N-terminal pro–B-type natriuretic peptide (NT-proBNP), a key biomarker for diagnosing heart failure, show a nearly fourfold increased risk for atrial fibrillation (AF) in at-risk ...

Background and aim: Cardiac troponin I (cTnI) and natriuretic peptide NT-proBNP are useful biomarkers in the evaluation of the sick heart. We aimed to detect a potential early postoperative myocardial ...

This new study investigated the relationship between cardiac function and hemodynamics among individuals presenting with heart failure with preserved ejection fraction (HFpEF) and normal levels of ...

The same N-terminal pro-B-type natriuretic peptides (NT-proBNP) concentration could mean drastically different absolute risks of heart failure (HF) for different demographics, according to a cohort ...

In this new subanalysis of data from the Atherosclerosis Risk in the Communities study, investigators assessed the risk of incident heart failure (HF) or death by race and sex, as influenced by ...

Please provide your email address to receive an email when new articles are posted on . NT-proBNP may predict CV death, incident HF and fatal or nonfatal CV events after acute MI. The association was ...

A blood biomarker may identify individuals with asymptomatic non-severe aortic stenosis (AS) who can benefit from more frequent check-ups, as well as those who can safely defer care, a study suggested ...

BOSTON, MA—Baseline levels of NT-proBNP, as well as early changes in levels of the biomarker, provide prognostic information among patients with severe tricuspid regurgitation (TR) undergoing ...

Please provide your email address to receive an email when new articles are posted on . Cancer survivors with increased NT-proBNP levels had an elevated risk for all-cause and cardiac mortality.

NT-proBNP is a cornerstone biomarker in the diagnosis and management of heart failure. Despite its widespread use, important biological and analytical challenges remain. One of the most significant is ...